Vilya is a biotech startup built off technology developed at the Seattle-based Institute for Protein Design. They use advanced machine learning and AI techniques to help develop macrocyclic drugs, a promising new type of medicine. Vilya aims to leverage cutting-edge computing to change how new medicines are designed and ultimately cure diseases.